115 related articles for article (PubMed ID: 34881777)
21. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
[TBL] [Abstract][Full Text] [Related]
22. Phosphoproteome of signaling by ErbB2 in ovarian cancer cells.
Sidhanth C; Bindhya S; Krishnapriya S; Manasa P; Shabna A; Alifia J; Patole C; Kumar V; Garg M; Ganesan TS
Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140768. PubMed ID: 35158093
[TBL] [Abstract][Full Text] [Related]
23. Lapatinib antitumor activity is not dependent upon phosphatase and tensin homologue deleted on chromosome 10 in ErbB2-overexpressing breast cancers.
Xia W; Husain I; Liu L; Bacus S; Saini S; Spohn J; Pry K; Westlund R; Stein SH; Spector NL
Cancer Res; 2007 Feb; 67(3):1170-5. PubMed ID: 17283152
[TBL] [Abstract][Full Text] [Related]
24. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
[TBL] [Abstract][Full Text] [Related]
25. The adaptor protein VEPH1 interacts with the kinase domain of ERBB2 and impacts EGF signaling in ovarian cancer cells.
Kollara A; Burt BD; Ringuette MJ; Brown TJ
Cell Signal; 2023 Jun; 106():110634. PubMed ID: 36828346
[TBL] [Abstract][Full Text] [Related]
26. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
27. Copine-III interacts with ErbB2 and promotes tumor cell migration.
Heinrich C; Keller C; Boulay A; Vecchi M; Bianchi M; Sack R; Lienhard S; Duss S; Hofsteenge J; Hynes NE
Oncogene; 2010 Mar; 29(11):1598-610. PubMed ID: 20010870
[TBL] [Abstract][Full Text] [Related]
28. Photo-activated psoralen binds the ErbB2 catalytic kinase domain, blocking ErbB2 signaling and triggering tumor cell apoptosis.
Xia W; Gooden D; Liu L; Zhao S; Soderblom EJ; Toone EJ; Beyer WF; Walder H; Spector NL
PLoS One; 2014; 9(2):e88983. PubMed ID: 24551203
[TBL] [Abstract][Full Text] [Related]
29. LIM and SH3 protein-1 modulates CXCR2-mediated cell migration.
Raman D; Sai J; Neel NF; Chew CS; Richmond A
PLoS One; 2010 Apr; 5(4):e10050. PubMed ID: 20419088
[TBL] [Abstract][Full Text] [Related]
30. The LIM and SH3 domain protein family: structural proteins or signal transducers or both?
Grunewald TG; Butt E
Mol Cancer; 2008 Apr; 7():31. PubMed ID: 18419822
[TBL] [Abstract][Full Text] [Related]
31. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
[TBL] [Abstract][Full Text] [Related]
32. Screening and identification of small molecule inhibitors of ErbB2-induced invasion.
Brix DM; Rafn B; Bundgaard Clemmensen K; Andersen SH; Ambartsumian N; Jäättelä M; Kallunki T
Mol Oncol; 2014 Dec; 8(8):1703-18. PubMed ID: 25070180
[TBL] [Abstract][Full Text] [Related]
33. Lasp-1 regulates podosome function.
Stölting M; Wiesner C; van Vliet V; Butt E; Pavenstädt H; Linder S; Kremerskothen J
PLoS One; 2012; 7(4):e35340. PubMed ID: 22514729
[TBL] [Abstract][Full Text] [Related]
34. PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells.
Jegg AM; Ward TM; Iorns E; Hoe N; Zhou J; Liu X; Singh S; Landgraf R; Pegram MD
Breast Cancer Res Treat; 2012 Dec; 136(3):683-92. PubMed ID: 23089982
[TBL] [Abstract][Full Text] [Related]
35. Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling.
Parashar D; Nair B; Geethadevi A; George J; Nair A; Tsaih SW; Kadamberi IP; Gopinadhan Nair GK; Lu Y; Ramchandran R; Uyar DS; Rader JS; Ram PT; Mills GB; Pradeep S; Chaluvally-Raghavan P
Cancer Res; 2020 Dec; 80(24):5554-5568. PubMed ID: 33087324
[TBL] [Abstract][Full Text] [Related]
36. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
Awasthi S; Hamburger AW
J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179
[TBL] [Abstract][Full Text] [Related]
37. [Impact of LASP-1 expression on proliferation and tumorigenesis of human colorectal cancer cell line SW480].
Zhao L; Ding YQ
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):830-4. PubMed ID: 21215099
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.
Salvi A; Bongarzone I; Ferrari L; Abeni E; Arici B; De Bortoli M; Scuri S; Bonini D; Grossi I; Benetti A; Baiocchi G; Portolani N; De Petro G
Int J Oncol; 2015 May; 46(5):1901-12. PubMed ID: 25760690
[TBL] [Abstract][Full Text] [Related]
39. Role of LASP-1, a novel SOX9 transcriptional target, in the progression of lung cancer.
Shi J; Guo J; Li X
Int J Oncol; 2018 Jan; 52(1):179-188. PubMed ID: 29138807
[TBL] [Abstract][Full Text] [Related]
40. TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion.
Chevalier C; Collin G; Descamps S; Touaitahuata H; Simon V; Reymond N; Fernandez L; Milhiet PE; Georget V; Urbach S; Lasorsa L; Orsetti B; Boissière-Michot F; Lopez-Crapez E; Theillet C; Roche S; Benistant C
Nat Commun; 2016 Feb; 7():10765. PubMed ID: 26899482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
